5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice
Authors:
Open Access
- 1 August 2016
- journal article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 131 (4) , 284-287
Abstract
No abstract availableKeywords
Funding Information
- Toyama Prefectural Government
This publication has 14 references indexed in Scilit:
- Involvement of mast cells and proteinase-activated receptor 2 in oxaliplatin-induced mechanical allodynia in micePharmacological Research, 2016
- Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)Journal of Clinical Oncology, 2015
- Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivativesActa Oncologica, 2015
- A focus on mast cells and painJournal of Neuroimmunology, 2013
- 5‐HT1A receptors are involved in the effects of xaliproden on G‐protein activation, neurotransmitter release and nociceptionBritish Journal of Pharmacology, 2009
- Xaliproden lessens oxaliplatin-mediated neuropathyThe Lancet Oncology, 2006
- Allergic-type reactions to oxaliplatin: Retrospective analysis of 42 patientsEuropean Journal of Cancer, 2005
- The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouseBritish Journal of Pharmacology, 1998
- Comparison of the effects of benzodiazepine and non-benzodiazepine anxiolytics on agonistic behavior in male mice.Folia Pharmacologica Japonica, 1992
- Ethopharmacology of maternal aggression in mice: effects of diazepam and SM-3997European Journal of Pharmacology, 1991